0 Comentários
0 Compartilhamentos
94 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Cancer Gene Therapy Market: Reimbursement Models Evolve for High-Cost Curative TreatmentsA new growth forecast report titled Cancer Gene Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy (Oncolytic Virotherapy, Gene Transfer); By End-Use (Research Institutes, Biopharma Companies); By Region; Segment Forecast, 2022 - 2030 introduced by Polaris Market Research represents conclusive data on the overall market. It majorly targets to provide a detailed analysis of...0 Comentários 0 Compartilhamentos 154 Visualizações 0 Anterior
-
mTOR Inhibitor Oncology Drug Market Grows with Breakthroughs in Targeted Cancer Therapy"Executive Summary mTOR Inhibitor Oncology Drug Market Size and Share Forecast CAGR Value The global mTOR inhibitor oncology drug market size was valued at USD 2.52 billion in 2025 and is expected to reach USD 5.32 billion by 2033, at a CAGR of 9.80% during the forecast period Competitive analysis performed in this mTOR Inhibitor Oncology Drug Market...0 Comentários 0 Compartilhamentos 47 Visualizações 0 Anterior
-
CAD/CAM Dental Devices Market Revenue Analysis: Growth, Share, Value, Size, and Insights"Executive Summary CAD/CAM Dental Devices Market Size and Share Across Top Segments Data Bridge Market Research analyses that the CAD/CAM Dental Devices market which was USD 2.5 Billion in 2022, is expected to reach USD 5.3 Billion by 2030, and is expected to undergo a CAGR of 13.2% during the forecast period 2023-2030. This global CAD/CAM Dental Devices Market report...0 Comentários 0 Compartilhamentos 7K Visualizações 0 Anterior
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Comentários 0 Compartilhamentos 168 Visualizações 0 Anterior
-
Cervical Cancer Treatment Market Outlook 2025–2033: Growth, Trends & ForecastMarket Overview The global cervical cancer treatment market size was valued at USD 8.47 billion in 2024 and is expected to grow from USD 8.88 billion in 2025 to USD 12.91 billion by 2033, growing at a CAGR of 4.8% during the forecast period (2025-2033). The global Cervical Cancer Treatment market continues to evolve rapidly, driven by shifting...0 Comentários 0 Compartilhamentos 737 Visualizações 0 Anterior
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Comentários 0 Compartilhamentos 137 Visualizações 0 Anterior
-
How are new therapies reshaping the urothelial cancer drugs market?Competitive Analysis of Executive Summary Urothelial Cancer Drugs Market Size and Share CAGR Value The global Urothelial Cancer Drugs market size was valued at USD 1.44 billion in 2024 and is expected to reach USD 2.80 billion by 2032, at a CAGR of 8.7% during the forecast period Keeping into consideration the customer requirement, an influential Urothelial Cancer Drugs...0 Comentários 0 Compartilhamentos 460 Visualizações 0 Anterior
-
Linear Particle Accelerators Market Opportunities: Growth, Share, Value, Size, and Scope"Comprehensive Outlook on Executive Summary Linear Particle Accelerators Market Size and Share Global linear particle accelerators market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account from USD 2,346.51 million in 2020 to USD 3,672.77 million by 2028 growing at a CAGR of 5.76% in the above-mentioned...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Precision Oncology: The 2026 Shift Toward Oral Small Molecules and Combination Targeted Regimens"Global Executive Summary Small Molecule Targeted Cancer Therapy Market Market: Size, Share, and Forecast Data Bridge Market Research analyses that the global small molecule targeted cancer therapy market which was USD 75,960.00 Million in 2022, would rocket up to USD 124,772.24 Million by 2030 and is expected to undergo a CAGR of 6.4% during the forecast period. The Small...0 Comentários 0 Compartilhamentos 24 Visualizações 0 Anterior
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Comentários 0 Compartilhamentos 214 Visualizações 0 Anterior
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Comentários 0 Compartilhamentos 189 Visualizações 0 Anterior
-
What advancements are shaping the Waldenstrom’s macroglobulinemia treatment market?Key Drivers Impacting Executive Summary Waldenstrom’s Macroglobulinemia (WM) Treatment Market Size and Share CAGR Value The Global Waldenstrom’s Macroglobulinemia (WM) Treatment Market size was valued at USD 160.50 million in 2024 and is expected to reach USD 228.70 million by 2032, at a CAGR of 5.20% during the forecast period Analysis and discussion of important...0 Comentários 0 Compartilhamentos 368 Visualizações 0 Anterior
Páginas Impulsionadas
English
Kiswahili
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
